Atlas Trials

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Clinical trial NCT03324932 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03324932
Sponsor
Kyoto Prefectural University of Medicine
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-09-25
Primary completion
2023-12-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.